Tier 3 · Filer Universe

GYRE THERAPEUTICS, INC.

GYRE · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.

Price
$6.05
+0.00%
Coverage
Tier 3
Tier 3 · Filer Universe
SEC CIK
0001124105
Liquidity rank
#4502
Observed dollar volume

Tier 3 is a directory treatment. It does not imply options, analyst estimates, or complete company-facts coverage. Missing fields stay missing.

SEC XBRL facts

FieldValuePeriod endFiling
Annual revenue$116.59M2025-12-310001193125-26-106251
Annual diluted EPS0.022025-12-310001193125-26-106251
Quarterly revenue$22.52M2026-03-310001193125-26-214676
Quarterly diluted EPS-0.12026-03-310001193125-26-214676

SEC EDGAR Frames batch generated 2026-07-16T23:27:27.057Z. Frames are calendar-aligned and may not cover every filer or fiscal period.

Filings and machine access

Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract

Context paths

HealthcareNasdaqBMY · Tier 1 peerTMO · Tier 1 peerDHR · Tier 1 peerAMGN · Tier 1 peer

Provenance

IdentitySEC company tickers and Nasdaq Symbol Directory
Quote and corporate actionsYahoo Finance chart
FundamentalsSEC EDGAR Frames